We are live on ! Find out more
CAM

ClariVest Asset Management Portfolio holdings

AUM $980M
1-Year Est. Return 60.89%
This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$1.84B
AUM Growth
-$155M
Cap. Flow
-$103M
Cap. Flow %
-5.59%
Top 10 Hldgs %
39.94%
Holding
870
New
213
Increased
171
Reduced
234
Closed
56

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$16.9M
2
META icon
Meta Platforms (Facebook)
META
+$13.7M
3
LLY icon
Eli Lilly
LLY
+$13.3M
4
PHM icon
Pultegroup
PHM
+$8.88M
5
OC icon
Owens Corning
OC
+$7.01M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$16.5M
2
TMO icon
Thermo Fisher Scientific
TMO
+$12.8M
3
AAPL icon
Apple
AAPL
+$12.4M
4
MSFT icon
Microsoft
MSFT
+$11.7M
5
NVDA icon
NVIDIA
NVDA
+$11.5M

Sector Composition

Rank Sector Weight
1 Technology 42.68%
2 Healthcare 14.34%
3 Consumer Discretionary 12.96%
4 Communication Services 9.89%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HST icon
801
Host Hotels & Resorts
HST
$16B
-91
Closed -$2K
HSY icon
802
Hershey
HSY
$36.6B
-8
Closed -$2K
PPLI
803
People Inc
PPLI
$3.1B
$0 ﹤0.01%
+11
New +$534
IDT icon
804
IDT Corp
IDT
$1.62B
$0 ﹤0.01%
13
-38,941
-100% -$917K
IMXI icon
805
International Money Express
IMXI
$367M
-56,685
Closed -$1.39M
INCY icon
806
Incyte
INCY
$24.4B
$0 ﹤0.01%
8
IOVA icon
807
Iovance Biotherapeutics
IOVA
$2.87B
$0 ﹤0.01%
122
-95
-44% -$620
ITOS
808
DELISTED
iTeos Therapeutics
ITOS
-35,255
Closed -$467K
KELYA icon
809
Kelly Services Class A
KELYA
$528M
$0 ﹤0.01%
23
-43
-65% -$776
KRG icon
810
Kite Realty
KRG
$5.36B
$0 ﹤0.01%
23
-42
-65% -$951
L icon
811
Loews
L
$23.6B
$0 ﹤0.01%
+7
New +$436
LH icon
812
Labcorp
LH
$25.9B
$0 ﹤0.01%
+2
New +$422
LW icon
813
Lamb Weston
LW
$7.19B
-15,599
Closed -$1.79M
MEI icon
814
Methode Electronics
MEI
$592M
$0 ﹤0.01%
13
-24
-65% -$715
MEOH icon
815
Methanex
MEOH
$4.12B
-40
Closed -$2K
MGNI icon
816
Magnite
MGNI
$3.55B
$0 ﹤0.01%
43
-75,885
-100% -$818K
MKC icon
817
McCormick & Company Non-Voting
MKC
$14.2B
$0 ﹤0.01%
+6
New +$501
MKTX icon
818
MarketAxess Holdings
MKTX
$5.72B
-3,606
Closed -$942K
MRNA icon
819
Moderna
MRNA
$23.6B
$0 ﹤0.01%
+4
New +$446
NEM icon
820
Newmont
NEM
$119B
$0 ﹤0.01%
+8
New +$325
NOC icon
821
Northrop Grumman
NOC
$81.2B
$0 ﹤0.01%
+1
New +$439
NSA
822
DELISTED
National Storage Affiliates Trust
NSA
-31,070
Closed -$1.08M
NSSC icon
823
Napco Security Technologies
NSSC
$1.48B
-35,045
Closed -$1.21M
OMC icon
824
Omnicom Group
OMC
$23.4B
-86,885
Closed -$8.27M
OTIS icon
825
Otis Worldwide
OTIS
$28.2B
$0 ﹤0.01%
+6
New +$513

Similar funds

ClariVest Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, ClariVest Asset Management held 870 positions worth $1.84B, down 7.8% from $1.99B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

ClariVest Asset Management withdrew a net $103M in Q3 2023, closing 56 positions and reducing 234 holdings. Its most notable exit was SS&C Technologies, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, ClariVest Asset Management opened a new position in Owens Corning worth $6.96M.

  • ClariVest Asset Management's largest Q3 2023 buy was Owens Corning: 51,032 shares worth $6.96M.
  • ClariVest Asset Management added most to TJX Companies in Q3 2023, an estimated $16.9M increase.
  • ClariVest Asset Management's biggest Q3 2023 reduction was Merck, cutting an estimated $16.5M.
  • ClariVest Asset Management fully exited SS&C Technologies in Q3 2023, selling an estimated $11.2M.
  • ClariVest Asset Management's ten largest holdings make up 40% of its $1.84B portfolio in Q3 2023.
  • ClariVest Asset Management opened 213 new positions and closed 56 in Q3 2023.
  • ClariVest Asset Management's portfolio value fell 7.8% quarter-over-quarter to $1.84B.

Based on ClariVest Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.